Real world outcomes of 2,339 patients with early-stage triple-negative breast cancer (TNBC) treated in British Columbia.

被引:0
作者
Lucas, Mairi
Chia, Stephen K. L.
Speers, Caroline
Lohrisch, Caroline A.
Nichol, Alan
Mitri, Zahi Ibrahim
机构
[1] British Columbia Canc Agcy, Vancouver, BC, Canada
[2] BC Breast Canc Outcomes Unit, Vancouver, BC, Canada
[3] BC Canc, Vancouver, BC, Canada
[4] Univ British Columbia, BC Canc Agcy, Vancouver, BC, Canada
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e23274
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Exploring Real-World HER2-Low Data in Early-Stage Triple-Negative Breast Cancer: Insights and Implications
    da Silva, Jesse Lopes
    Carvalho, Giselle de Souza
    de Albuquerque, Lucas Zanetti
    Rodrigues, Fabiana Resende
    Fernandes, Priscila Valverde
    Kischinhevsky, Daniel
    de Melo, Andreia Cristina
    BREAST CANCER-TARGETS AND THERAPY, 2023, 15 : 337 - 347
  • [32] Patterns of Chemotherapy Utilization among Elderly Patients with Early-Stage Triple-Negative Breast Cancer
    Malinowski, Catalina
    Lei, Xiudong
    Giordano, Sharon
    Chavez, Marianna
    CANCER RESEARCH, 2024, 84 (09)
  • [33] Prospect of neoadjuvant/adjuvant immunotherapy in early-stage triple-negative breast cancer
    Hao, Xiaopeng
    Gao, Xianqi
    Yin, Shanshan
    Jiang, Zefei
    TRANSLATIONAL BREAST CANCER RESEARCH, 2023, 4
  • [34] Tislelizumab: an effective treatment option for early-stage triple-negative breast cancer
    Yu, Zhigang
    TRANSLATIONAL BREAST CANCER RESEARCH, 2024, 5
  • [35] MUC1 expression in early-stage triple-negative breast cancer
    Miedler, J.
    Abdul-Karim, F.
    Wang, N.
    Baar, J.
    CANCER RESEARCH, 2009, 69 (02) : 207S - 207S
  • [36] MicroRNA in diagnosis and therapy monitoring of early-stage triple-negative breast cancer
    Kahraman, Mustafa
    Roeske, Anne
    Laufer, Thomas
    Fehlmann, Tobias
    Backes, Christina
    Kern, Fabian
    Kohlhaas, Jochen
    Schroers, Hannah
    Saiz, Anna
    Zabler, Cassandra
    Ludwig, Nicole
    Fasching, Peter A.
    Strick, Reiner
    Ruebner, Matthias
    Beckmann, Matthias W.
    Meese, Eckart
    Keller, Andreas
    Schrauder, Michael G.
    SCIENTIFIC REPORTS, 2018, 8
  • [37] Early-stage Triple-negative Breast Cancer: Time to Optimize Personalized Strategies
    Abuhadra, Nour
    Stecklein, Shane
    Sharma, Priyanka
    Moulder, Stacy
    ONCOLOGIST, 2022, 27 (01) : 30 - 39
  • [38] MicroRNA in diagnosis and therapy monitoring of early-stage triple-negative breast cancer
    Mustafa Kahraman
    Anne Röske
    Thomas Laufer
    Tobias Fehlmann
    Christina Backes
    Fabian Kern
    Jochen Kohlhaas
    Hannah Schrörs
    Anna Saiz
    Cassandra Zabler
    Nicole Ludwig
    Peter A. Fasching
    Reiner Strick
    Matthias Rübner
    Matthias W. Beckmann
    Eckart Meese
    Andreas Keller
    Michael G. Schrauder
    Scientific Reports, 8
  • [39] TNBC-DX genomic test in early-stage triple-negative breast cancer treated with neoadjuvant taxane-based therapy without immunotherapy
    Martin Jimenez, M.
    Gluz, O.
    Villacampa, G.
    Lopez-Tarruella Cobo, S.
    Nitz, U. A.
    Cobo, S.
    Braso-Maristany, F.
    Christgen, M.
    Jerez Gilarranz, Y.
    Kummel, S.
    Conte, B.
    Diaz-Guardamino, I. Echavarria
    Graeser-Mayer, M. K.
    Kreipe, H.
    Del Monte-Millan, M.
    Herrero Lopez, B.
    Perou, C. M.
    Pare Brunet, L.
    Prat, A.
    Harbeck, N.
    ANNALS OF ONCOLOGY, 2024, 35 : S312 - S312
  • [40] Chemotherapy regimen choice and patient outcomes in early-stage triple-negative breast cancer: a retrospective analysis
    Ghafouri, Sanaz N.
    Nayeri, Rebecca W.
    McAndrew, Nicholas P.
    Hurvitz, Sara A.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14